Minerva Neurosciences (NERV) Notes Payables (2013 - 2018)

Minerva Neurosciences' Notes Payables history runs 6 years deep, the most recent figure standing at $1.4 million for Q2 2018.

• Quarterly Notes Payables fell 72.43% year-over-year to $1.4 million in Q2 2018, while the trailing twelve-month figure through Jun 2018 was $1.4 million (down 72.43% YoY) and the FY2017 annual result came in at $4.0 million, down 18.36% from the prior year.
• Notes Payables was $1.4 million for Q2 2018 at Minerva Neurosciences, down from $2.7 million in the prior quarter.
• Across five years, Notes Payables topped out at $5.2 million in Q3 2017 and bottomed at $158263.0 in Q1 2015.
• A 5-year average of $3.0 million and a median of $2.7 million in 2018 frame the typical range for Notes Payables.
• Annual changes were most pronounced in 2016 — Notes Payables jumped 1788.21% — and 2018, when it plunged 72.43%.
• Minerva Neurosciences' Notes Payables stood at $2.0 million in 2014, then declined by 28.53% to $1.4 million in 2015, then soared by 238.3% to $4.9 million in 2016, then retreated by 18.36% to $4.0 million in 2017, then sank by 64.75% to $1.4 million in 2018.
• Business Quant data shows NERV's Notes Payables at $1.4 million in Q2 2018, $2.7 million in Q1 2018, and $4.0 million in Q4 2017.